Aptevo Therapeutics Inc. Revenue, Net (Deprecated 2018-01-31)
Aptevo Therapeutics Inc. (APVO) reported Revenue, Net (Deprecated 2018-01-31) of $4.07 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-05-10
- Aptevo Therapeutics Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $4.07M, a 90.06% increase year-over-year.
- Aptevo Therapeutics Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.82M, a 67.86% decline year-over-year.
- Aptevo Therapeutics Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.17M, a 119.18% increase year-over-year.
- Aptevo Therapeutics Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $10.76M, a 5.60% increase year-over-year.
- Aptevo Therapeutics Inc. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $14.66M, a 46.80% increase from fiscal 2016.
- Aptevo Therapeutics Inc. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $9.98M, a 70.28% decline from fiscal 2015.
- Aptevo Therapeutics Inc. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $33.60M.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $4.07M 10-Q · filed 2018-05-10 | $6.89M derived: sum of 2 quarters · filed 2018-05-10 | $13.06M derived: sum of 3 quarters · filed 2018-05-10 | $23.82M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $8.99M derived: sum of 2 quarters · filed 2018-03-13 | $19.75M derived: sum of 3 quarters · filed 2018-03-13 | $14.66M 10-K · filed 2018-03-13 | |||
| 2017-09-30 | $6.17M 10-Q · filed 2017-11-13 | $16.94M derived: sum of 2 quarters · filed 2017-11-13 | $11.84M 10-Q · filed 2017-11-13 | $27.85M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-06-30 | $10.76M 10-Q · filed 2017-08-10 | $18.17M 10-Q · filed 2017-08-10 | $21.68M derived: sum of 3 quarters · filed 2018-05-10 | $24.49M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-03-31 | $2.14M 10-Q · filed 2018-05-10 | $7.41M 10-Q · filed 2017-05-12 | $10.91M derived: sum of 2 quarters · filed 2018-05-10 | $13.73M derived: sum of 3 quarters · filed 2018-05-10 | $23.92M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | $8.77M 10-K · filed 2017-03-31 | $11.59M derived: sum of 2 quarters · filed 2017-11-13 | $21.78M derived: sum of 3 quarters · filed 2017-11-13 | $9.98M 10-K · filed 2018-03-13 | $36.43M 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $2.82M 10-Q · filed 2017-11-13 | $9.40M 10-Q · filed 2016-11-14 | $13.01M derived: sum of 2 quarters · filed 2017-11-13 | $7.20M 10-Q · filed 2017-11-13 | $27.66M 10-Q · filed 2016-11-14 | $29.36M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $10.19M 10-Q · filed 2017-08-10 | $18.26M 10-Q · filed 2017-08-10 | $26.55M derived: sum of 3 quarters · filed 2017-08-10 | $33.11M derived: sum of 4 quarters · filed 2017-08-10 | |||
| 2016-03-31 | $8.07M 10-Q · filed 2017-05-12 | $16.35M derived: sum of 2 quarters · filed 2017-05-12 | $22.91M derived: sum of 3 quarters · filed 2017-05-12 | $30.00M derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | $8.29M 10-K · filed 2017-03-31 | $14.85M derived: sum of 2 quarters · filed 2017-03-31 | $21.94M derived: sum of 3 quarters · filed 2017-03-31 | $33.60M 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $6.56M 10-K · filed 2017-03-31 | $13.65M derived: sum of 2 quarters · filed 2017-03-31 | $25.32M 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $7.09M 10-K · filed 2017-03-31 | $18.75M 10-Q/A · filed 2016-09-22 | |||||
| 2015-03-31 | $11.66M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |